Free Trial

Integer (ITGR) Competitors

Integer logo
$129.10 -6.12 (-4.53%)
As of 10:51 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

ITGR vs. BAX, HOLX, GMED, MASI, TFX, ATRC, IART, ATEC, OFIX, and SRDX

Should you be buying Integer stock or one of its competitors? The main competitors of Integer include Baxter International (BAX), Hologic (HOLX), Globus Medical (GMED), Masimo (MASI), Teleflex (TFX), AtriCure (ATRC), Integra LifeSciences (IART), Alphatec (ATEC), Orthofix Medical (OFIX), and Surmodics (SRDX). These companies are all part of the "health care equipment" industry.

Integer vs.

Integer (NYSE:ITGR) and Baxter International (NYSE:BAX) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their community ranking, valuation, institutional ownership, earnings, media sentiment, risk, profitability, analyst recommendations and dividends.

In the previous week, Baxter International had 4 more articles in the media than Integer. MarketBeat recorded 26 mentions for Baxter International and 22 mentions for Integer. Baxter International's average media sentiment score of 0.55 beat Integer's score of 0.41 indicating that Baxter International is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Integer
7 Very Positive mention(s)
2 Positive mention(s)
10 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Baxter International
10 Very Positive mention(s)
1 Positive mention(s)
8 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

Integer currently has a consensus price target of $146.56, suggesting a potential upside of 13.52%. Baxter International has a consensus price target of $39.40, suggesting a potential upside of 17.64%. Given Baxter International's higher probable upside, analysts plainly believe Baxter International is more favorable than Integer.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Integer
0 Sell rating(s)
2 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.78
Baxter International
1 Sell rating(s)
6 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.20

Baxter International has higher revenue and earnings than Integer. Integer is trading at a lower price-to-earnings ratio than Baxter International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Integer$1.60B2.71$90.65M$3.2439.85
Baxter International$14.81B1.15$2.66B$0.20167.47

Integer has a net margin of 6.70% compared to Baxter International's net margin of 0.77%. Baxter International's return on equity of 18.30% beat Integer's return on equity.

Company Net Margins Return on Equity Return on Assets
Integer6.70% 11.63% 5.86%
Baxter International 0.77%18.30%5.43%

99.3% of Integer shares are owned by institutional investors. Comparatively, 90.2% of Baxter International shares are owned by institutional investors. 2.0% of Integer shares are owned by insiders. Comparatively, 0.2% of Baxter International shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Baxter International received 345 more outperform votes than Integer when rated by MarketBeat users. Likewise, 65.59% of users gave Baxter International an outperform vote while only 63.88% of users gave Integer an outperform vote.

CompanyUnderperformOutperform
IntegerOutperform Votes
389
63.88%
Underperform Votes
220
36.12%
Baxter InternationalOutperform Votes
734
65.59%
Underperform Votes
385
34.41%

Integer has a beta of 1.13, indicating that its stock price is 13% more volatile than the S&P 500. Comparatively, Baxter International has a beta of 0.61, indicating that its stock price is 39% less volatile than the S&P 500.

Summary

Integer and Baxter International tied by winning 9 of the 18 factors compared between the two stocks.

Get Integer News Delivered to You Automatically

Sign up to receive the latest news and ratings for ITGR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ITGR vs. The Competition

MetricIntegerElectromedical equipment IndustryMedical SectorNYSE Exchange
Market Cap$4.34B$3.41B$5.81B$20.24B
Dividend YieldN/A1.65%4.78%3.65%
P/E Ratio39.9315.4725.9335.55
Price / Sales2.7163.18463.3316.39
Price / Cash18.0345.9944.0420.85
Price / Book2.833.967.715.00
Net Income$90.65M$92.00M$3.18B$1.02B
7 Day Performance-8.40%-0.26%-0.52%0.50%
1 Month Performance-9.76%1.77%1.71%0.16%
1 Year Performance30.99%14.21%18.52%15.96%

Integer Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ITGR
Integer
2.6182 of 5 stars
$129.10
-4.5%
$146.56
+13.5%
+35.4%$4.34B$1.60B39.9310,500Earnings Report
Analyst Downgrade
News Coverage
BAX
Baxter International
4.2573 of 5 stars
$30.83
+0.7%
$39.44
+27.9%
-20.0%$15.74B$14.81B154.1660,000Earnings Report
Analyst Forecast
News Coverage
HOLX
Hologic
4.8881 of 5 stars
$63.24
-0.6%
$85.77
+35.6%
-13.8%$14.27B$4.03B19.957,063
GMED
Globus Medical
4.8634 of 5 stars
$83.99
-0.2%
$96.91
+15.4%
+55.5%$11.44B$1.57B125.365,000Earnings Report
Analyst Forecast
News Coverage
Positive News
MASI
Masimo
3.108 of 5 stars
$181.31
+1.0%
$191.40
+5.6%
+34.8%$9.71B$2.05B125.045,200Analyst Revision
Positive News
TFX
Teleflex
4.5305 of 5 stars
$167.44
-0.1%
$252.50
+50.8%
-30.2%$7.78B$3.03B33.2914,500News Coverage
ATRC
AtriCure
4.0068 of 5 stars
$40.94
+3.4%
$51.56
+25.9%
+18.6%$2.00B$399.24M-49.331,200
IART
Integra LifeSciences
2.6075 of 5 stars
$24.18
-0.3%
$23.00
-4.9%
-51.3%$1.87B$1.54B-268.643,946
ATEC
Alphatec
4.3669 of 5 stars
$10.74
-1.3%
$17.56
+63.5%
-30.8%$1.52B$572.74M-8.39700
OFIX
Orthofix Medical
3.1737 of 5 stars
$18.61
+1.6%
$23.33
+25.4%
+31.5%$711.09M$746.64M-5.951,634Upcoming Earnings
SRDX
Surmodics
3.5267 of 5 stars
$34.10
-0.2%
$50.00
+46.6%
+8.9%$487.63M$126.08M-33.76450Analyst Revision

Related Companies and Tools


This page (NYSE:ITGR) was last updated on 2/21/2025 by MarketBeat.com Staff
From Our Partners